Tanika Curry
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tanika Curry has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Alyssa Grant
Ottawa Hospital Research Institute (OHRI) Ottawa Ontario Canada
1 shared publication- Andrea Lasso
Ottawa Hospital Research Institute (OHRI) Ottawa Ontario Canada
1 shared publication Emily Wener
Department of Otolaryngology—Head and Neck Surgery University of Ottawa Ottawa Ontario Canada
1 shared publication- Kednapa Thavorn
The Ottawa Hospital Research Institute, Ottawa, Canada
1 shared publication Lisa Caulley
Ottawa Hospital Research Institute (OHRI) Ottawa Ontario Canada
1 shared publicationMichael Odell
Department of Otolaryngology—Head and Neck Surgery University of Ottawa Ottawa Ontario Canada
1 shared publication
Latest Publications
- Open Access
- 4 February 2026
- Published by Wiley in The Laryngoscope
- Vol. 136 (6) , 2598-2604
Choice and Death: Analysis of Medical Assistance in Dying for Head and Neck Cancer in Ontario
Objective: There is a paucity of information on the uptake of Medical Assistance in Dying (MAiD) for patients with head and neck cancer (HNC). Our study reports the prevalence, disease characteristics, and nature of the desire for MAiD in patients with HNC who underwent the process in Ontario. The aim is to better understand this population and identify gaps in our current system of care. Methods: This is a retrospective cross‐sectional analysis for the period June 17, 2016 to December 31, 2022. Data were received from the Office of the Chief Coroner Ontario, Canada. Results: Three hundred and fifty‐six persons received MAiD. The average age was 72.4 years (SD 12.22) with 260 of the patients being men (73.03%). The most common HNC primary tumor site was the oral cavity 109 (30.6%). The most reported reason was inadequate control of symptoms other than pain (79.21%) followed by inadequate pain control or concerns about it (75%). The patient's private residence (55.62%) was the most common setting. Patients were more likely to live in wealthier neighborhoods and in large urban centers. Future prediction of MAiD uptake shows a linear year‐by‐year increase. Conclusion: The use of MAiD in HNC has been steadily increasing since its legalization and is projected to continue increasing. There is a male predominance that is aligned with the incidence and prevalence of HNC nationally. Overall, MAiD is an increasingly employed choice for HNC patients receiving treatment for disease without curative intent. Level of Evidence: 4
- 4 February 2026
- Published by Wiley in The Laryngoscope
- Vol. 136 (6) , 2598-2604
Open AccessChoice and Death: Analysis of Medical Assistance in Dying for Head and Neck Cancer in Ontario
Objective: There is a paucity of information on the uptake of Medical Assistance in Dying (MAiD) for patients with head and neck cancer (HNC). Our study reports the prevalence, disease characteristics, and nature of the desire for MAiD in patients with HNC who underwent the process in Ontario. The aim is to better understand this population and identify gaps in our current system of care. Methods: This is a retrospective cross‐sectional analysis for the period June 17, 2016 to December 31, 2022. Data were received from the Office of the Chief Coroner Ontario, Canada. Results: Three hundred and fifty‐six persons received MAiD. The average age was 72.4 years (SD 12.22) with 260 of the patients being men (73.03%). The most common HNC primary tumor site was the oral cavity 109 (30.6%). The most reported reason was inadequate control of symptoms other than pain (79.21%) followed by inadequate pain control or concerns about it (75%). The patient's private residence (55.62%) was the most common setting. Patients were more likely to live in wealthier neighborhoods and in large urban centers. Future prediction of MAiD uptake shows a linear year‐by‐year increase. Conclusion: The use of MAiD in HNC has been steadily increasing since its legalization and is projected to continue increasing. There is a male predominance that is aligned with the incidence and prevalence of HNC nationally. Overall, MAiD is an increasingly employed choice for HNC patients receiving treatment for disease without curative intent. Level of Evidence: 4